MetLife, Inc.

DB:MWZ Stock Report

Market Cap: €54.8b

MetLife Valuation

Is MWZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MWZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MWZ (€80.28) is trading below our estimate of fair value (€138.08)

Significantly Below Fair Value: MWZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MWZ?

Key metric: As MWZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MWZ. This is calculated by dividing MWZ's market cap by their current earnings.
What is MWZ's PE Ratio?
PE Ratio16.2x
EarningsUS$3.56b
Market CapUS$57.70b

Price to Earnings Ratio vs Peers

How does MWZ's PE Ratio compare to its peers?

The above table shows the PE ratio for MWZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.6x
MUV2 Münchener Rückversicherungs-Gesellschaft in München
11x2.9%€62.6b
HNR1 Hannover Rück
12.9x5.7%€28.9b
ALV Allianz
11.8x6.0%€111.3b
TLX Talanx
10.7x4.9%€20.3b
MWZ MetLife
16.2x13.2%€57.7b

Price-To-Earnings vs Peers: MWZ is expensive based on its Price-To-Earnings Ratio (16.2x) compared to the peer average (11.6x).

Price to Earnings Ratio vs Industry

How does MWZ's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
MWZ 16.2xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MWZ is expensive based on its Price-To-Earnings Ratio (16.2x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is MWZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MWZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.2x
Fair PE Ratio11.8x

Price-To-Earnings vs Fair Ratio: MWZ is expensive based on its Price-To-Earnings Ratio (16.2x) compared to the estimated Fair Price-To-Earnings Ratio (11.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MWZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€80.28
€86.12
+7.3%
9.3%€96.07€64.68n/a13
Nov ’25€72.07
€82.04
+13.8%
8.6%€90.10€62.52n/a13
Oct ’25€73.31
€76.81
+4.8%
7.8%€85.98€60.90n/a13
Sep ’25€69.83
€74.91
+7.3%
7.2%€85.78€60.76n/a12
Aug ’25€70.01
€77.37
+10.5%
8.6%€88.96€61.16n/a13
Jul ’25€64.68
€76.65
+18.5%
8.9%€92.51€61.67n/a13
Jun ’25€65.04
€76.49
+17.6%
9.1%€91.89€61.26n/a13
May ’25€66.79
€77.46
+16.0%
10.8%€97.87€62.11n/a14
Apr ’25€68.54
€73.58
+7.3%
8.0%€81.42€61.06n/a14
Mar ’25€64.03
€73.58
+14.9%
8.0%€81.42€61.06n/a14
Feb ’25€59.95
€72.51
+20.9%
8.4%€80.96€57.96n/a15
Jan ’25€59.31
€70.83
+19.4%
7.9%€78.89€57.79n/a15
Dec ’24€57.86
€70.40
+21.7%
8.6%€79.28€58.08n/a15
Nov ’24€56.60
€72.31
+27.8%
8.6%€80.09€59.36€72.0714
Oct ’24€59.39
€72.45
+22.0%
8.7%€79.87€59.20€73.3114
Sep ’24€59.41
€70.45
+18.6%
10.9%€78.68€53.69€69.8314
Aug ’24€57.14
€66.30
+16.0%
11.6%€75.60€51.59€70.0114
Jul ’24€51.63
€67.81
+31.3%
10.7%€78.04€53.25€64.6814
Jun ’24€46.73
€70.38
+50.6%
11.4%€80.47€56.14€65.0414
May ’24€55.45
€69.27
+24.9%
10.1%€78.39€54.69€66.7916
Apr ’24€52.98
€74.51
+40.6%
10.1%€83.95€55.97€68.5416
Mar ’24€66.84
€75.08
+12.3%
7.2%€82.47€57.73€64.0316
Feb ’24€66.04
€75.64
+14.5%
7.6%€85.65€58.02€59.9516
Jan ’24€67.37
€76.63
+13.7%
6.8%€82.58€59.80€59.3115
Dec ’23€72.97
€78.61
+7.7%
7.0%€84.43€61.14€57.8615
Nov ’23€73.89
€78.63
+6.4%
5.9%€84.96€64.49€56.6016

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

China Life Insurance

HK$824.2b

Operates as a life insurance company in the People’s Republic of China.

CLF

HK$5.95

7D

0%

1Y

-22.2%

China Life Insurance

HK$1.1t

Operates as a life insurance company in the People’s Republic of China.

CHL

HK$1.90

7D

-3.6%

1Y

46.8%

AXA

€72.3b

Through its subsidiaries, provides insurance, asset management, and banking services worldwide.

AXA

€34.20

7D

-0.6%

1Y

20.7%